CLINICAL_TRIALS
trial_result
· 2021-09-24
Clinical Trial Update: DOACs for Stroke Prevention Post Ventricular Tachycardia Ablation [Phase 4]
Summary
Phase 4 clinical trial update evaluating direct oral anticoagulants for stroke prevention after ventricular tachycardia ablation; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Kansas City Heart Rhythm Institute | Conditions: Ventricular Tachycardia, Premature Ventricular Contraction | Phase 4 | Status: COMPLETED | Results posted: 2021-09-24